(Q51470585)

5 April 2018

title

Evidence for distinct effects of GH and IGF-I in the metabolic syndrome. (English)

1 reference

5 April 2018

1 reference

P Maison

1

1 reference

5 April 2018

B Balkau

2

1 reference

5 April 2018

J-C Souberbielle

3

1 reference

5 April 2018

P Cunin

4

1 reference

5 April 2018

S Vol

5

1 reference

5 April 2018

I Macquin-Mavier

6

1 reference

5 April 2018

E Eschwège

7

1 reference

5 April 2018

D. E. S. I. R. Study Group

8

1 reference

5 April 2018

publication date

29 May 2007

1 reference

5 April 2018

published in

Diabetic Medicine

1 reference

5 April 2018

volume

24

1 reference

5 April 2018

issue

9

1 reference

5 April 2018

page(s)

1012-1018

1 reference

5 April 2018

The metabolic syndrome--a new worldwide definition

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Low circulating IGF-II concentrations predict weight gain and obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Are the metabolic effects of GH and IGF-I separable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Acute Metabolic Effects of Human Growth Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Transcriptional regulation of fatty acid synthase gene by somatotropin in 3T3-F442A adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

The mechanism of effect of growth hormone on preadipocyte and adipocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02195.X

10.1111/J.1464-5491.2007.02195.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018